Osimertinib As First-Line Treatment of EGFR Mutation–Positive Advanced Non–Small-Cell Lung Cancer Atezolizumab data from clinical trials in non–small-cell lung cancer, metastatic urothelial carcinoma, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results